UCB Pharma GmbH

UCB Pharma GmbH logo
🇩🇪Germany
Ownership
Subsidiary
Established
1946-01-01
Employees
51
Market Cap
-
Website
http://www.ucb.de

Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy

First Posted Date
2012-08-27
Last Posted Date
2016-11-15
Lead Sponsor
UCB Pharma GmbH
Target Recruit Count
315
Registration Number
NCT01673282
Locations
🇩🇪

17, Osnabrück, Germany

🇩🇪

14, Radeberg, Germany

🇩🇪

13, Kehl-Kork, Germany

and more 39 locations

Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s Disease

First Posted Date
2012-05-28
Last Posted Date
2018-04-04
Lead Sponsor
UCB Pharma GmbH
Target Recruit Count
93
Registration Number
NCT01606670
Locations
🇩🇪

5, Alzenau, Germany

🇩🇪

16, Altenholz, Germany

🇩🇪

22, Bad Honnef, Germany

and more 24 locations

Change in Gastrointestinal Complaints After Switch From Oral Parkinson's Disease Treatment to Neupro® Transdermal Patch

First Posted Date
2010-07-09
Last Posted Date
2013-05-21
Lead Sponsor
UCB Pharma GmbH
Target Recruit Count
76
Registration Number
NCT01159691
Locations
🇩🇪

28, Goettingen, Germany

🇩🇪

02, Berlin, Germany

🇩🇪

35, Nürnberg, Germany

and more 18 locations

Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug

Completed
Conditions
First Posted Date
2010-04-02
Last Posted Date
2014-09-03
Lead Sponsor
UCB Pharma GmbH
Target Recruit Count
576
Registration Number
NCT01098162
Locations
🇩🇪

13, Ulm, Germany

🇩🇪

99, Kleve, Germany

🇩🇪

36, Bielefeld, Germany

and more 110 locations

Observation of Treatment With Certolizumab Pegol in Daily Practice

Completed
Conditions
First Posted Date
2010-02-17
Last Posted Date
2015-10-29
Lead Sponsor
UCB Pharma GmbH
Target Recruit Count
1117
Registration Number
NCT01069419
Locations
🇩🇪

13, Bad Neuenahr-Ahrweiler, Germany

🇩🇪

87, Bad Staffelstein, Germany

🇩🇪

115, Bautzen, Germany

and more 160 locations
© Copyright 2024. All Rights Reserved by MedPath